Tenth Annual

Boston Symposium on organic & bioorganic chemisty

November 4th, 2021
  • Home
  • Register
  • Committee
  • Agenda
  • Speakers
  • Posters

Agenda

  • 9:00 - Organizer's Welcome

    Daniel Smaltz, Senior Principal Scientist, Pfizer

  • 9:15 - 9:35 Synthesis and Study of Complex Molecule Antibiotics

    Kyan D’Angelo, Mo Movassaghi group, Massachusetts Institute of Technology

  • 9:35 - 9:55 Rational Design of Bifunctional Molecules That Alter the Specificity of Serine/Threonine and Tyrosine Kinases

    Veronika Shoba, Amit Choudhary group, Broad Institute & Harvard Institutes of Medicine

  • 9:55 - 10:15 Shotgun Kinetic Target-Guided Synthesis Approach Enables the Discovery of Small Molecule Inhibitors Against Pathogenic Amoeba Glucokinases

    Mintesinot Kassu, Roman Manetsch group, Northeastern University

  • 10:15 - 10:35 Unraveling Cysteine Oxidation in the Mitochondria

    Eleni Kisty, Eranthie Weerapana group, Boston College

  • 10:35 - Virtual Poster Session 1

  • 11:20 Break

  • 11:35 - Keynote Presentation: Target Identification With Photo-Affinity Labeling

    Christina Woo, Associate Professor of Chemistry and Chemical Biology, Harvard University

  • 12:35pm - Lunch break

  • 1:35 - Afternoon Session Opening Remarks

    Emma Edelstein, Senior Scientist, Merck

  • 1:40 - 2:00 Deep Learning to Design Nuclear-Targeting Abiotic Miniproteins

    Carly Schissel, Bradley Pentelute group, Massachusetts Institute of Technology

  • 2:00 - 2:20 Novel Reaction Discovery with Rapid HTS via Infrared Spectroscopy and Electrochemical Enzyme Catalysis

    Jessie Zhen, Scott Schaus group, Boston University

  • 2:20 - 2:40 Molecular Design of Secretin Peptides to Modulate Receptor Function

    Kathleen Sicinski, Krishna Kumar group, Tufts University

  • 2:40 - 3:00 Identifying Scaffolding and Allosteric Functions of LSD1 in AML

    Amanda Waterbury, Brian Liau group, Harvard University

  • 3:00 - Virtual Poster Session 2

  • 3:45 - Break

  • 3:55 - Keynote Presentation: Oral Inhibitors of the SARS-CoV-2 Main Protease for the Treatment of COVID-19

    Dafydd Owen, Senior Science Director, Medicine Design, Pfizer

  • 4:50 - Closing Remarks

    Lei Zhang, Senior Director, Medicine Design, Pfizer

  • 5:00 - Symposium Closes

Website development by Facta Studio.